| Item Type | Name |
|
Concept
|
Transplantation, Homologous
|
|
Academic Article
|
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
|
|
Academic Article
|
Autologous and allogeneic transplantation for aggressive NHL.
|
|
Academic Article
|
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
|
|
Academic Article
|
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
|
|
Academic Article
|
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
|
|
Academic Article
|
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
|
|
Academic Article
|
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
|
|
Academic Article
|
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
|
|
Academic Article
|
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
The next frontier for stem cell transplantation: finding a donor for all.
|
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Chimerism does not predict for outcome after alemtuzumab based conditioning.
|
|
Academic Article
|
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
|
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
|
Academic Article
|
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
|
|
Academic Article
|
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants.
|
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity.
|
|
Academic Article
|
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.
|
|
Academic Article
|
Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization.
|
|
Academic Article
|
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
|
|
Academic Article
|
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
|
|
Academic Article
|
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.
|
|
Academic Article
|
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.
|
|
Academic Article
|
Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
|
Academic Article
|
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
|
|
Academic Article
|
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
|
|
Academic Article
|
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
|
|
Academic Article
|
Nonmyeloablative conditioning for relapsed follicular lymphoma.
|
|
Academic Article
|
Microchimerism and allogeneic transplantation: we need the proof in the pudding.
|
|
Academic Article
|
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
|
|
Academic Article
|
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
|
|
Academic Article
|
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
|
|
Academic Article
|
Low-grade lymphoma.
|
|
Academic Article
|
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.
|
|
Academic Article
|
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
|
|
Academic Article
|
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
|
|
Academic Article
|
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
|
|
Academic Article
|
Autologous and allogeneic stem cell transplantation in follicular lymphoma.
|
|
Academic Article
|
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
|
|
Academic Article
|
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia.
|
|
Academic Article
|
Hematopoietic stem cell transplantation for myelofibrosis.
|
|
Academic Article
|
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
|
|
Academic Article
|
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
|
|
Academic Article
|
Allogeneic transplantation for low-grade lymphoma: long-term follow-up.
|
|
Academic Article
|
Treatment of relapse after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
|
|
Academic Article
|
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.
|
|
Academic Article
|
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
|
|
Academic Article
|
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
|
|
Academic Article
|
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.
|
|
Academic Article
|
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
|
|
Academic Article
|
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
|
|
Academic Article
|
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
|
|
Academic Article
|
Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence.
|
|
Academic Article
|
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
|
|
Academic Article
|
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
|
|
Academic Article
|
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
|
|
Academic Article
|
Studies of decitabine with allogeneic progenitor cell transplantation.
|
|
Academic Article
|
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
|
|
Academic Article
|
Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization.
|
|
Academic Article
|
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
|
|
Academic Article
|
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
|
|
Academic Article
|
Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy.
|
|
Academic Article
|
Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
|
|
Academic Article
|
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
|
|
Academic Article
|
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
|
|
Academic Article
|
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
|
|
Academic Article
|
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Allogeneic bone marrow transplantation for low-grade lymphoma.
|
|
Academic Article
|
Alemtuzumab in allogeneic hematopoetic stem cell transplantation.
|
|
Academic Article
|
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.
|
|
Academic Article
|
Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions.
|
|
Academic Article
|
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
|
|
Academic Article
|
Stem-cell transplantation for sickle cell disease.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
|
|
Academic Article
|
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
|
|
Academic Article
|
Reduced-intensity and nonmyeloablative conditioning regimens.
|
|
Academic Article
|
The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.
|
|
Academic Article
|
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
|
|
Academic Article
|
Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
|
|
Academic Article
|
Standardizing chronic graft-versus-host disease.
|
|
Academic Article
|
Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.
|
|
Academic Article
|
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
|
|
Academic Article
|
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?
|
|
Academic Article
|
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
|
|
Academic Article
|
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
|
|
Academic Article
|
Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum.
|
|
Academic Article
|
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
|
|
Academic Article
|
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.
|
|
Academic Article
|
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.
|
|
Academic Article
|
Second allogeneic transplantation: ever? never? or sometimes.
|
|
Academic Article
|
Cord blood chimerism and relapse after haplo-cord transplantation.
|
|
Academic Article
|
Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplant.
|
|
Academic Article
|
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
|
|
Academic Article
|
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
|
|
Academic Article
|
Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?
|
|
Academic Article
|
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response.
|
|
Academic Article
|
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
|
|
Academic Article
|
Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectations.
|
|
Academic Article
|
Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!
|
|
Academic Article
|
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
|
|
Grant
|
Busulfan conditioning: optimization, kinetics, genomics
|
|
Grant
|
Minor Histocompatilibity Vaccination After Allo-Transpl*
|
|
Academic Article
|
Immune reconstitution inflammatory syndrome in a patient with M.haemophilum infection after allogeneic hematopoietic stem cell transplantation.
|